Bacfo Pharmaceuticals (India ) Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 2.61 Cr
as on 24-10-2024
- Company Age 30 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 27.10 Cr
as on 24-10-2024
- Satisfied Charges ₹ 8.61 Cr
as on 24-10-2024
- Revenue 55.98%
(FY 2023)
- Profit 64.32%
(FY 2023)
- Ebitda 78.92%
(FY 2023)
- Net Worth 49.29%
(FY 2023)
- Total Assets 96.22%
(FY 2023)
About Bacfo Pharmaceuticals (India )
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 2.61 Cr.
The company currently has active open charges totaling ₹27.10 Cr. The company has closed loans amounting to ₹8.61 Cr, as per Ministry of Corporate Affairs (MCA) records.
Arun Chauhan, Rajesh Puri, Akhil Chauhan, and One other member serve as directors at the Company.
- CIN/LLPIN
U74899DL1994PLC062272
- Company No.
062272
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
20 Oct 1994
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Bacfo Pharmaceuticals (India ) Limited offer?
Bacfo Pharmaceuticals (India ) Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Guggul, Digestive System Drugs & Medicines, Antacid Drugs.
Who are the key members and board of directors at Bacfo Pharmaceuticals (India )?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arun Chauhan  | Managing Director | 21-Oct-1994 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajesh Puri | Director | 01-Jul-2006 | Current |
| Achal Chauhan | Additional Director | 07-Mar-2013 | Current |
| Akhil Chauhan | Director | 28-Dec-2006 | Current |
Financial Performance and Corporate Structure Insights of Bacfo Pharmaceuticals (India ).
Bacfo Pharmaceuticals (India ) Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 55.98% increase. The company also saw a substantial improvement in profitability, with a 64.32% increase in profit. The company's net worth Soared by an impressive increase of 49.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bacfo Pharmaceuticals (India )?
In 2023, Bacfo Pharmaceuticals (India ) had a promoter holding of 86.59% and a public holding of 13.41%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
_LIMITED.webp)
Cincorp International LimitedActive 16 years 1 monthArun Chauhan, Akhil Chauhan and 1 more are mutual person
- I Finance Company LimitedActive 13 years 11 months
Arun Chauhan, Akhil Chauhan and 1 more are mutual person
- Crobols-Cross Border Legal Systems (India) Private LimitedActive 28 years 8 months
Arun Chauhan is a mutual person
_LIMITED.webp)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 21 Nov 2022 | ₹3.00 Cr | Open |
Hdfc Bank Limited Creation Date: 26 Aug 2022 | ₹3.35 M | Open |
Axis Bank Limited Creation Date: 30 Apr 2022 | ₹6.00 Cr | Open |
How Many Employees Work at Bacfo Pharmaceuticals (India )?
Bacfo Pharmaceuticals (India ) has a workforce of 168 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bacfo Pharmaceuticals (India ), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bacfo Pharmaceuticals (India )'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
